Cumberland pharmaceuticals inc stock
WebCumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its … Web3.1 The Company may issue up to 125,000 shares of Stock, subject to the adjustment provisions of Section 8, in Awards granted hereunder. Such shares may be either authorized but unissued shares or shares issued and thereafter acquired by the Company.
Cumberland pharmaceuticals inc stock
Did you know?
Web1. Grant of Option. Cumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from the Company up to the number of shares of common stock in the Company (the “Shares”) described in the attached Notice of Stock Option Grant (the “Notice”). WebCumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300 Nashville, TN 37203 Phone: (615) 255-0068 Toll Free: (877) 484-2700 Fax: (615) 255-0094. …
WebApr 6, 2024 · Cumberland Pharmaceuticals Inc lowest stock price was $1.89 and its highest was $2.91 in the past 12 months. What is Cumberland Pharmaceuticals Inc’s market cap? ... Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. ...
WebDec 21, 2024 · The estimated net worth of Martin E. Cearnal is at least $382,925.28 as of July 30th, 2024. Mr. Cearnal owns 165,054 shares of Cumberland Pharmaceuticals stock worth more than $382,925 as of February 24th. This net worth estimate does not reflect any other assets that Mr. Cearnal may own. WebApr 11, 2024 · CUMBERLAND PHARMACEUTICALS INC. : CPIX Stock Price US2307701092 MarketScreener Homepage Equities United States Nasdaq Cumberland Pharmaceuticals Inc. Summary CPIX US2307701092 CUMBERLAND PHARMACEUTICALS INC. (CPIX) Add to my list Report Summary Quotes Charts News …
WebApr 12, 2024 · Another comparable company Nektar Therapeutics (NKTR) saw its stock close 10.53% higher in the most recent trading session but was down -83.85% in a year. Furthermore, Cumberland Pharmaceuticals Inc. (CPIX) showed an increase of 2.12% on the day while its price kept declining at -36.30% over the past year.
WebJul 22, 2009 · THIS WARRANT TO PURCHASE COMMON STOCK OF CUMBERLAND PHARMACEUTICALS, INC. (the “Warrant”) is issued as of July 22, 2009, by … little bully pulpit mini golfWebThe purpose of the Cumberland Pharmaceuticals Inc. 2007 Directors’ Incentive Plan is to promote the interests of the Company and its shareholders by strengthening the … little bumps all over babyWebCumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2024 financial results and provided a Company … Discover historical prices for CPIX stock on Yahoo Finance. View daily, weekly or … Find the latest Cumberland Pharmaceuticals Inc. (CPIX) stock … Stocks sink after Fed minutes despite cooler inflation: Stock market news … Find out all the key statistics for Cumberland Pharmaceuticals Inc. … Cumberland Pharmaceuticals Inc. (CPIX) NasdaqGS - NasdaqGS Real Time … Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty … Cumberland Pharmaceuticals Inc. (CPIX) NasdaqGS - NasdaqGS Real Time … Cumberland Pharmaceuticals Inc. 1600 West End Avenue Nashville, TN 37203 … See Cumberland Pharmaceuticals Inc. (CPIX) stock analyst estimates, … Get the detailed quarterly/annual income statement for Cumberland … little bump on fingerWebJul 17, 2024 · Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is … little bump on my headWebApr 6, 2024 · The Cumberland Pharmaceuticals Inc. stock price gained 2.55% on the last trading day (Thursday, 6th Apr 2024), rising from $1.96 to $2.01. During the last trading … little bum bumWebMar 24, 2024 · BOSTON (MarketWatch) -- Cumberland Pharmaceuticals shares dropped in pre-market trading after the specialty drug maker issued a sales forecast that came in … little bumps inside labiaWebOur gross margins remained attractive, resulting in $8.5 million in cash generated from operations. Our balance sheet remained strong as we ended the year with $93 million in total assets – including $20 million in cash, $57 million in liabilities and $36 million of shareholders’ equity. little bumps above lip